S. Friberg et S. Mattson, ON THE GROWTH-RATES OF HUMAN-MALIGNANT TUMORS - IMPLICATIONS FOR MEDICAL DECISION-MAKING, Journal of surgical oncology, 65(4), 1997, pp. 284-297
Testicular carcinomas, pediatric tumors, and some mesenchymal tumors a
re examples of rapidly proliferating cell populations, for which the t
umor volume doubling time (TVDT) can be counted in days. Cancers from
the breast: prostate, and colon are frequently slow-growing, displayin
g a TVDT of months or years. irrespective of their growth rates, most
human tumors have been found: to start from one single cell, to have a
long subclinical period, to grow at constant rates for long periods o
f time, to start to metastasize often even before the primary is detec
ted, and to have metastases that often grow at approximately the same
rate as tile primary tumor. The recognition of basic facts in tumor ce
ll kinetics is essential in the evaluation of important present-day st
rategies in oncology, Among the facts emphasized in this review are: (
1) Screening programs. Most tumors are several years old when detectab
le by present-day diagnostic methods. This makes the term ''early dete
ction'' questionable. (2) Legal trials. The importance of so-called do
ctor's delay is often discussed, bur the prognostic value of ''early''
detection is overestimated (3) Analyses of clinical trials. Such anal
ysis may be differentiated depending on the growth rates of the type o
f tumor studied. Furthermore, uncritical analysis of survival data may
be misleading if the TVDT is not taken into consideration. (4) Analys
es of epidemiological data. If causes of malignant tumors in humans ar
e searched for, the time of exposure must be extended far back in the
subject's history. (5) Risk estimations by insurance companies. For th
e majority of human cancers, the 5-year survival rate is not a valid m
easurement for cure, Thus, basic knowledge of tumor kinetics may have
important implications for political health programs, legal trials, me
dical science. and insurance policies. (C) 1997 Wiley-Liss, Inc.